|
JPS5264452A
(en)
|
1975-11-18 |
1977-05-27 |
Nippon Suisan Kaisha Ltd |
Method of producing processed fish meat
|
|
JPS5820575B2
(ja)
|
1975-11-27 |
1983-04-23 |
日本水産株式会社 |
スイサンカコウヒンノセイゾウホウ
|
|
US4273763A
(en)
|
1978-01-23 |
1981-06-16 |
Efamol Limited |
Pharmaceutical and dietary compositions
|
|
IE47777B1
(en)
*
|
1978-01-23 |
1984-06-13 |
Efamol Ltd |
Pharmaceutical and dietary composition comprising gamma-linolenic acids
|
|
US4444755A
(en)
|
1978-01-23 |
1984-04-24 |
Efamol Limited |
Treatment for skin disorders
|
|
DE2967049D1
(en)
|
1978-04-11 |
1984-07-19 |
Efamol Ltd |
Pharmaceutical and dietary composition comprising gamma-linolenic acids
|
|
IE49783B1
(en)
*
|
1979-05-18 |
1985-12-11 |
Efamol Ltd |
Pharmaceutical and dietary composition comprising epsilon-linolenic acids
|
|
IE51145B1
(en)
|
1980-03-07 |
1986-10-15 |
Efamol Ltd |
Pharmaceutical and dietary compositions
|
|
IE53332B1
(en)
|
1980-03-14 |
1988-10-26 |
Efamol Ltd |
Pharmaceutical compositions
|
|
US5324748A
(en)
|
1981-07-14 |
1994-06-28 |
Efamol Limited |
Method for enhancement of 1-series PG production
|
|
DE3363567D1
(en)
|
1982-03-01 |
1986-06-26 |
Efamol Ltd |
Pharmaceutical and dietary composition
|
|
DE3366838D1
(en)
|
1982-03-01 |
1986-11-20 |
Efamol Ltd |
Pharmaceutical composition
|
|
EP0087865B1
(en)
|
1982-03-01 |
1986-10-01 |
Efamol Limited |
Pharmaceutical composition
|
|
IE54795B1
(en)
|
1982-04-29 |
1990-02-14 |
Efamol Ltd |
Pharmaceutical composition
|
|
GB8302708D0
(en)
*
|
1983-02-01 |
1983-03-02 |
Efamol Ltd |
Pharmaceutical and dietary composition
|
|
GB8319073D0
(en)
|
1983-07-14 |
1983-08-17 |
Efamol Ltd |
Fatty acid compositions
|
|
GB8326130D0
(en)
|
1983-09-29 |
1983-11-02 |
Efamol Ltd |
Topical preparations containing tars and fatty acids
|
|
GB8420771D0
(en)
|
1984-08-15 |
1984-09-19 |
Efamol Ltd |
Treatment of skin disorders
|
|
GB8425006D0
(en)
|
1984-10-03 |
1984-11-07 |
Efamol Ltd |
Composition of copper/fatty acids
|
|
GB8506027D0
(en)
|
1985-03-08 |
1985-04-11 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
|
GB8522670D0
(en)
|
1985-09-13 |
1985-10-16 |
Efamol Ltd |
Drug treatments
|
|
GB8524275D0
(en)
|
1985-10-02 |
1985-11-06 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
|
US5198468A
(en)
|
1987-06-24 |
1993-03-30 |
Efamol Holdings Plc |
Essential fatty acid composition
|
|
EP0309086A1
(en)
|
1987-09-07 |
1989-03-29 |
Efamol Holdings Plc |
Treatment of male pattern baldness and of unwanted hair growth
|
|
GB8729153D0
(en)
|
1987-12-14 |
1988-01-27 |
Efamol Ltd |
Fatty acid compositions
|
|
US5352700A
(en)
|
1988-01-14 |
1994-10-04 |
Anders Frithz |
Use of essential fatty acids for the preparation of a drug for the treatment of infantile seborrheic eczema
|
|
GB8806737D0
(en)
|
1988-03-22 |
1988-04-20 |
Efamol Holdings |
Therapeutic composition & method
|
|
CA1334002C
(en)
|
1988-09-28 |
1995-01-17 |
Barry D. Sears |
Essential fatty acid compositions and methods for the modulation of prostaglandin levels in mammals
|
|
US6140304A
(en)
|
1988-09-28 |
2000-10-31 |
Eicotech Corporation |
Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
|
|
GB8916734D0
(en)
*
|
1989-07-21 |
1989-09-06 |
Efamol Holdings |
Pharmaceutical and dietary uses of fatty acids
|
|
GB8918294D0
(en)
|
1989-08-10 |
1989-09-20 |
Efamol Holdings |
Pharmaceutical compositions
|
|
GB8920228D0
(en)
|
1989-09-07 |
1989-10-18 |
Efamol Holdings |
Fatty acid therapy
|
|
JPH04290820A
(ja)
|
1991-03-18 |
1992-10-15 |
Idemitsu Petrochem Co Ltd |
皮膚病犬の治療方法とその薬剤
|
|
GB9111900D0
(en)
*
|
1991-06-03 |
1991-07-24 |
Efamol Holdings |
Fatty acid compositions
|
|
GB9112052D0
(en)
*
|
1991-06-05 |
1991-07-24 |
Efamol Holdings |
Fatty acid treatment
|
|
JP3354581B2
(ja)
|
1991-09-30 |
2002-12-09 |
サントリー株式会社 |
ジホモ−γ−リノレン酸及びこれを含有する脂質の製造方法
|
|
GB9211229D0
(en)
|
1992-05-27 |
1992-07-08 |
Efamol Holdings |
Fatty acid treatment
|
|
US5888541A
(en)
|
1992-08-21 |
1999-03-30 |
Scotia Holdings Plc |
Fatty acid treatment
|
|
GB9217780D0
(en)
|
1992-08-21 |
1992-10-07 |
Efamol Holdings |
Fatty acid treatment
|
|
FI101039B
(fi)
|
1992-10-09 |
1998-04-15 |
Eeva Kristoffersson |
Menetelmä lääkepellettien valmistamiseksi
|
|
DE4238869C2
(de)
|
1992-11-18 |
1994-09-08 |
Wogepharm Gmbh |
Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
|
|
GB9301446D0
(en)
|
1993-01-26 |
1993-03-17 |
Scotia Holdings Plc |
Internal radiation damage
|
|
AU683027B2
(en)
*
|
1993-01-27 |
1997-10-30 |
Scotia Holdings Plc |
Triglycerides
|
|
CA2119000A1
(en)
|
1993-03-19 |
1994-09-20 |
David Frederick Horrobin |
Formulation for use in smokers
|
|
JPH09505562A
(ja)
*
|
1993-10-01 |
1997-06-03 |
アール．ピー．シェーラー コーポレイション |
香料を小分けして提供する方法および組成物
|
|
GB9403855D0
(en)
|
1994-03-01 |
1994-04-20 |
Scotia Holdings Plc |
Fatty acid derivatives
|
|
US5789441A
(en)
|
1996-02-15 |
1998-08-04 |
Virocell Inc. |
Leukotriene B4 as an antiviral and anti-neoplastic agent
|
|
GB9621373D0
(en)
|
1996-10-14 |
1996-12-04 |
Scotia Holdings Plc |
Fatty acid treatment
|
|
GB9710351D0
(en)
|
1997-05-20 |
1997-07-16 |
Scotia Holdings Plc |
Glucosamine fatty acids
|
|
GB9715444D0
(en)
*
|
1997-07-22 |
1997-09-24 |
Scotia Holdings Plc |
Therapeutic and dietary compositions
|
|
JP2000191525A
(ja)
|
1998-12-25 |
2000-07-11 |
Nof Corp |
皮膚外用剤組成物
|
|
GB9916536D0
(en)
|
1999-07-14 |
1999-09-15 |
Scarista Limited |
Nutritional or pharmaceutical compositions
|
|
DK1072198T3
(da)
*
|
1999-07-28 |
2008-09-22 |
Swiss Caps Rechte & Lizenzen |
Præparat til anvendelse som medikament og/eller ernæringstilskud
|
|
EP1762557B1
(en)
|
2000-02-16 |
2011-04-06 |
The Brigham And Women's Hospital, Inc. |
Aspirin-triggered lipid mediators
|
|
GB0016045D0
(en)
|
2000-06-29 |
2000-08-23 |
Laxdale Limited |
Therapeutic combinations of fatty acids
|
|
JP2002047176A
(ja)
*
|
2000-08-04 |
2002-02-12 |
Idemitsu Technofine Co Ltd |
ＩｇＥ産生抑制剤
|
|
US20020188024A1
(en)
|
2000-08-23 |
2002-12-12 |
Chilton Floyd H. |
Fatty acid-containing emulsion with increased bioavailability
|
|
US20040043013A1
(en)
|
2000-12-28 |
2004-03-04 |
Mccleary Edward Larry |
Metabolic uncoupling therapy
|
|
DE10121252A1
(de)
|
2001-04-30 |
2002-11-07 |
Christos C Zouboulis |
Behandlung der Akne
|
|
ATE291910T1
(de)
|
2001-05-30 |
2005-04-15 |
Laxdale Ltd |
Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen
|
|
JP2003155233A
(ja)
|
2001-11-16 |
2003-05-27 |
Idemitsu Technofine Co Ltd |
塗布剤
|
|
AU2003299034A1
(en)
|
2002-09-20 |
2004-04-08 |
Griscom Bettle Iii |
Transdermal compositions
|
|
KR20050083960A
(ko)
|
2002-11-22 |
2005-08-26 |
닛폰 스이산 가부시키가이샤 |
고도 불포화 지방산, 그 염, 또는 그 에스테르를 함유하는외용 조성물
|
|
US20050032757A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Cho Suk H. |
Nutritional supplements
|
|
JP2005179211A
(ja)
|
2003-12-17 |
2005-07-07 |
Idemitsu Kosan Co Ltd |
皮膚外用剤組成物
|
|
EP1711173A2
(en)
|
2003-12-31 |
2006-10-18 |
Igennus Limited |
Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or ester thereof
|
|
AU2005262392A1
(en)
|
2004-07-01 |
2006-01-19 |
Johnson & Johnson Vision Care, Inc. |
Compositions and methods for treating eye disorders and conditions
|
|
US7666447B2
(en)
*
|
2004-10-08 |
2010-02-23 |
Pharmanutrients |
Compositions including Krill extracts and conjugated linoleic acid and methods of using same
|
|
US7893106B2
(en)
|
2004-11-19 |
2011-02-22 |
Martek Biosciences, Corporation |
Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
|
|
JP5546087B2
(ja)
|
2005-02-14 |
2014-07-09 |
サントリーホールディングス株式会社 |
皮膚疾患経口治療または予防剤
|
|
JP2006306812A
(ja)
|
2005-04-28 |
2006-11-09 |
Suntory Ltd |
好酸球浸潤抑制剤
|
|
EP3581178B1
(en)
|
2005-02-14 |
2023-08-30 |
Suntory Holdings Limited |
Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
|
|
US7485323B2
(en)
|
2005-05-31 |
2009-02-03 |
Gelita Ag |
Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
|
|
TW200711649A
(en)
|
2005-06-17 |
2007-04-01 |
Combinatorx Inc |
Combination therapy for the treatment of immunoinflammatory disorders
|
|
JP5101894B2
(ja)
|
2007-01-15 |
2012-12-19 |
サントリーホールディングス株式会社 |
高度不飽和脂肪酸及びこれを含有する脂質の製造方法
|
|
ITMI20070555A1
(it)
|
2007-03-21 |
2007-06-20 |
Giuliani Spa |
Composizione provvista di attivita' di inibizione sulla 5 alfa-reduttasi
|
|
WO2009130291A2
(de)
|
2008-04-25 |
2009-10-29 |
Basf Plant Science Gmbh |
Pflanzensamenöl
|
|
GB0907413D0
(en)
|
2009-04-29 |
2009-06-10 |
Equateq Ltd |
Novel methods
|
|
CA2690488C
(en)
*
|
2010-01-19 |
2013-06-11 |
Accucaps Industries Limited |
Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
|
|
GB201001345D0
(en)
|
2010-01-27 |
2010-03-17 |
Equateq Ltd |
Process for preparing and purifying fatty acids
|
|
AU2011349718B2
(en)
|
2010-12-21 |
2017-02-09 |
Nestec S.A. |
Methods and compositions for preventing and treating osteoarthritis
|
|
US8293790B2
(en)
|
2011-10-19 |
2012-10-23 |
Dignity Sciences Limited |
Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
|
|
RU2014119948A
(ru)
|
2011-10-19 |
2015-11-27 |
Дигнити Сайенсиз Лимитед |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ DGLA И/ИЛИ 15-HETrE, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
JP2015500639A
(ja)
|
2011-11-29 |
2015-01-08 |
ディグニティ サイエンシス リミテッド |
２０−炭素脂肪酸を含む組成物ならびにその製造方法および使用方法
|
|
RS57777B1
(sr)
|
2012-01-06 |
2018-12-31 |
Omthera Pharmaceuticals Inc |
Dpa-obogaćene kompozicije omega-3 polinezasićenih masnih kiselina u obliku slobodne kiseline
|
|
US20120264705A1
(en)
|
2012-01-26 |
2012-10-18 |
Dignity Sciences Limited |
Antimicrobial compositions comprising 15-hetre and methods of use thereof
|
|
US20130267598A1
(en)
|
2012-02-23 |
2013-10-10 |
Dignity Sciences Limited |
Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same
|
|
WO2013150386A2
(en)
*
|
2012-04-04 |
2013-10-10 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
|
|
GB2504061A
(en)
*
|
2012-05-25 |
2014-01-22 |
Dignity Sciences Ltd |
Omega-6 Enriched PUFA Phospholipids
|
|
WO2014022816A2
(en)
|
2012-08-03 |
2014-02-06 |
Dignity Sciences Limited |
Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
|
|
GB201216385D0
(en)
*
|
2012-09-13 |
2012-10-31 |
Chrysalis Pharma Ag |
A pharmaceutical composition
|
|
US9682055B2
(en)
*
|
2014-06-04 |
2017-06-20 |
Dignity Sciences Limted |
Pharmaceutical compositions comprising DGLA and use of same
|
|
MA47141A
(fr)
|
2015-05-13 |
2019-11-06 |
Ds Biopharma Ltd |
Compositions comprenant du15-oxo-epa ou du 15-oxo-dgla et leurs procédés de préparation et d'utilisation
|
|
CA3027867A1
(en)
|
2016-01-07 |
2017-07-13 |
Ds Biopharma Limited |
Pharmaceutical compositions comprising dgla and use of same
|